Valneva SE - stock earnings
VALN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -36.2 million USD | 40.3 million USD |
| 2023Q2 | -18.4 million USD | 43.7 million USD |
| 2023Q1 | -19.8 million USD | 36.5 million USD |
| 2022Q4 | -47.4 million USD | 119.6 million USD |
| 2022Q3 | 71.0 million USD | 153.7 million USD |
| 2022Q2 | -27.2 million USD | 22.8 million USD |
| 2022Q1 | -29.1 million USD | 24.4 million USD |
| 2021Q4 | 196.2 million USD | 316.4 million USD |
| 2021Q3 | -184.8 million USD | 25.9 million USD |
| 2021Q2 | -69.6 million USD | 28.8 million USD |
| 2021Q1 | -32.5 million USD | 27.2 million USD |
| 2020Q4 | -2.5 million USD | 62.7 million USD |
| 2020Q3 | -43.0 million USD | 12.8 million USD |
| 2020Q2 | -27.4 million USD | 14.3 million USD |
| 2020Q1 | -1.4 million USD | 38.8 million USD |
| 2019Q4 | 772937 USD | 50.2 million USD |
| 2019Q3 | -36111 USD | 29.4 million USD |
| 2019Q2 | -8.2 million USD | 22.4 million USD |
| 2019Q1 | 5.4 million USD | 39.1 million USD |
| 2018Q4 | 7.5 million USD | 39.7 million USD |
| 2018Q3 | -3.6 million USD | 22.5 million USD |
| 2018Q2 | -1.9 million USD | 31.1 million USD |
| 2018Q1 | 1.8 million USD | 39.5 million USD |
| 2017Q4 | -4.4 million USD | 34.6 million USD |
| 2017Q3 | -4.1 million USD | 26.5 million USD |
| 2017Q2 | -3.1 million USD | 29.1 million USD |
| 2017Q1 | -1.8 million USD | 30.4 million USD |
| 2016Q4 | -2.9 million USD | 27.4 million USD |
| 2016Q3 | -7.9 million USD | 20.6 million USD |
| 2016Q2 | -38.3 million USD | 28.8 million USD |
| 2016Q1 | -5.7 million USD | 26.9 million USD |
| 2015Q4 | -17.9 million USD | 22.9 million USD |
| 2015Q3 | -5.8 million USD | 22.7 million USD |
| 2015Q2 | -9.9 million USD | 20.9 million USD |
| 2015Q1 | 10.6 million USD | 20.2 million USD |
| 2014Q4 | -14.0 million USD | 14.0 million USD |
| 2014Q3 | -3.3 million USD | 14.1 million USD |
| 2014Q2 | -6.9 million USD | 11.0 million USD |
| 2014Q1 | -9.8 million USD | 8.6 million USD |
| 2013Q4 | -8.1 million USD | 12.3 million USD |
| 2013Q3 | -13.5 million USD | 18.7 million USD |
| 2013Q2 | -7.3 million USD | 9.1 million USD |
| 2013Q1 | -3.3 million USD | 944538 USD |
| 2012Q4 | -4.9 million USD | 1.2 million USD |
| 2012Q3 | -3.1 million USD | 1.3 million USD |
VALN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -125.4 million USD | 169.9 million USD |
| 2022 | -153.8 million USD | 387.7 million USD |
| 2021 | -83.5 million USD | 395.9 million USD |
| 2020 | -78.4 million USD | 134.4 million USD |
| 2019 | -2.0 million USD | 141.4 million USD |
| 2018 | 3.7 million USD | 129.3 million USD |
| 2017 | -13.7 million USD | 125.7 million USD |
| 2016 | -51.8 million USD | 99.0 million USD |
| 2015 | -22.5 million USD | 85.7 million USD |
| 2014 | -32.0 million USD | 44.9 million USD |
| 2013 | -33.1 million USD | 42.0 million USD |
| 2012 | -17.1 million USD | 4.5 million USD |
| 2011 | -5.7 million USD | 13.3 million USD |
| 2010 | -10.6 million USD | 11.2 million USD |
| 2009 | -8.8 million USD | 4.4 million USD |
| 2008 | -3.3 million USD | 4.8 million USD |
| 2007 | -4.9 million USD | 1.3 million USD |
| 2006 | -320711 USD | 3.1 million USD |
| 2005 | -1.4 million USD | 3.6 million USD |
VALN
Price: $7.57
52 week price:
Earnings Per Share: -1.58 USD
P/E Ratio: -4.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 8187
Market Capitalization: 571.8 million